Health Related Quality of Life After Surgery and Oncological Treatment of Colorectal Liver Metastases (HQOL)

Haukeland University Hospital

Status: Unknown

Conditions: Quality of Life; Metastasis

Study type: Observational

Funder types: Other

Identifiers

NCT01587976

2011/570

Details and patient eligibility

About

The purpose of this trial is to study health related quality of life (HQoL)after resection of colorectal liver metastases combined with perioperative chemotherapy. The investigators want to study if an aggressive, life prolonging and multimodal treatment can be defended from a quality of life perspective.

Full description

Background: Hepatic resection is the only treatment with potential curative intent for patients having colorectal liver metastases. Combined with chemotherapy, the overall 5-year survival is 40-50%. The disease free 5-year survival is about 20%, and about 70% of resected patients experience recurrence from their disease. Even if surgery is superior all other treatments, most patients will finally die from their cancer. However; surgery contributes by adding years of life, and for a minority, a disease free life. There has been much effort to study predictors for outcome after surgery, but little has been focused on quality of life following this treatment.

Method: EORTC Validated questionnaire (European Organisation Research of Treatment of Cancer) version QLQ-C30 (3.0) and QLQ LMC21. The patients fill out the questionnaire before surgery as a baseline, and then after 3,6 and 12 months after surgery. The investigators also register important clinicopathological data about each patient prospectively.

Enrollment: 100 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Liver metastasis from colorectal cancer
• Resectability, with intension of R0 resection
• No macroscopic tumor left after surgery
• Patients with combined resectable extrahepatic tumors are also included.
• Patients must complete the questionnaire before the operation.

Exclusion criteria

• Drop out of questionnaire after surgery
• Patients found to be irresectable during the operation or where macroscopic tumor tissue are left behind.